ndegene Limited reported its financial results for the quarter and year ended March 31, 2025.
For Q4FY25, the company’s revenue from operations stood at ₹755.6 crore, marking an increase of 10% from ₹685 crore in the same quarter last year. Sequentially, revenue grew from ₹720.4 crore reported in Q3FY25.
Net profit for the March quarter rose 24% year-on-year to ₹117.6 crore, compared to ₹94.8 crore in Q4FY24. On a quarter-on-quarter basis, profit improved from ₹109.7 crore recorded in Q3FY25.
For the full financial year FY25:
Revenue from operations was ₹2,839.3 crore, up from ₹2,589.6 crore in FY24, registering a 10% annual growth.
Net profit for FY25 rose to ₹406.7 crore from ₹336.7 crore in FY24, reflecting a 21% growth.
Indegene, which specializes in healthcare solutions and digital services for the life sciences industry, continues to expand its capabilities across key geographies.
Disclaimer: This article is for informational purposes only. Investors are advised to consult certified financial advisors before making any investment decisions.
